Singapore Democratic Party (SDP) member Damanhuri Abas said that the support the party is getting now from the public is “more encouraging” compared to what it got in the last general election (GE).

He said following the GE2015, SDP continued walking the ground right after the party’s internal post-mortem of the election.

“I still remember the many dismissive residents, from chiding us to outright remarks to ‘not waste our time’. Nevertheless, Bryan Lim Boon Heng (林文兴) and I and even John L. Tan who sadly is disqualified for this election, remained steadfast and persevered,” Mr Damanhuri said in a Facebook post today (27 June).

He added that the party never gave up its believe that in order to improve SDP’s “collective condition”, it requires the party to take “real actions” and reach out to the people and “patiently persuade” them.

“Gradually and surely we gain ground and can pleasantly say that the reception we get today is so much more encouraging.”

However, the SDP member stated that changing the mindset and attitude of people was “daunting and formidable”, especially given that everything was against the party for decades.

In fact, Mr Damanhuri said that SDP may not win even after trying very hard, but it will continue to fight for the people of Singapore.

“We may strive and never win. But we will hold on to our believe to offer hope for real change and continue the fight for the common people none the less,” he wrote.

For the upcoming GE that is set to happen on 10 July, SDP’s chief Dr Chee Soon Juan confirmed during a walkabout at Bukit Batok West Shopping centre last weekend that he will be contesting in Bukit Batok SMC.

Dr Chee last contested in Bukit Batok SMC in the 2016 by-election – which took place following the sudden resignation of People’s Action Party (PAP) Member of Parliament (MP) David Ong – where he lost to the PAP’s Murali Pillai, who won with 61.21 per cent of the vote.

Apart from Dr Chee’s announcement, SDP has not made official confirmation on any other candidates and where they will be contesting. However, its walkabouts since Friday (19 June) strongly indicated which constituencies it will contest as well as who will be the representative, the Straits Times reported.

The party sent teams of four of the five constituencies it contested in 2015 – Bukit Batok SMC, Yuhua SMC, Holland-Bukit Timah GRC and Marsiling-Yew Tee GRC.

Today, the party is also holding another walkabout in the fifth constituency, Bukit Panjang SMC.

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
You May Also Like

MOH preliminarily confirms 344 new cases of COVID-19 infection ; Total tally at 31,960

As of Monday noon (25 May), the Ministry of Health (MOH) has…

Netizens call for a smoking ban after NEA investigates smoker caught on thermal camera in HDB corridor

The National Environment Agency (NEA) has gotten in touch with a resident…

巴蒂回乡圆梦有望啦! 情义之家成功筹获2.8万元

成功获改判无罪的前女佣巴蒂·莉雅妮(Parti Liyani),为了能让她返回印尼并开餐馆维持家计,客工援助组织情义之家(HOME)设立网上筹款活动,成功在一天内收到超过2万8000元的善款。 46岁的印尼籍前女佣,曾在樟宜机场集团主席廖文良家中帮佣近九年,于2016年10月28日被开除后,遭前雇主父子报警指控偷走逾五万元的财物。而巴蒂在被开除当天就返回印尼,后因廖家父子的指控,于2016年12月2日回到我国时被逮捕。 为了配合调查,巴蒂自2016年12月就滞留在本地,但因无法工作,她就一直居住在由情义之家所经营的收容所内,依靠该组织的援助至今已将近四年。 案件终于在上周五(9月4日),由高庭推翻国家法院的判决,改判巴蒂无罪。巴蒂受访时表示,她被逮捕至今,都不敢告诉母亲真实情况,因为不想让母亲担心。 情义之家在昨日(9月6日)通过筹款网站Giving.sg,为巴蒂设立筹款活动,希望能够帮助巴蒂早日回乡,展开新生并完成设立餐馆的梦想。 对于判决,情义之家在声明中指出,在接受调查、审判和上诉过程中都一路陪伴着巴蒂,当局很高兴巴蒂取得司法胜利,定罪完全被推翻。“巴蒂在过去四年都无法工作赚取收入,而您的捐款将能够帮助到她,让她重建生活并实现自己的梦想。” 此外,情义之家也感叹,客工在面对指控时遭遇不公对待。 声明中,情义之家指出,涉案的客工无法得知调查需要多长时间,且不被允许工作也不能离境。有些无辜的客工就是因此而选择认罪,因为服刑的时间可能会比法庭程序所需的时间来的短。 该组织表示,在律法前面应该人人平等,不该因为工作准证级别或国籍而有所变动,更应该让他们获得律师代表的机会。 该组织放眼筹获2万8000元,而在短短一天内,有关的金额已达标,甚至超出了。筹款活动已截止,该组织成功为巴蒂筹获2万8560元。

直销“套路”鹿胎素有治癌疗效 卫生科学局证“绝无此事”

卫生科学局(HSA)点名警告保健直销公司力汇国际(Riway International),禁止该公司对消费者宣传旗下保健食品有治愈癌症的误导信息。 根据《海峡时报》报道,卫生科学局日前发现,力汇国际的最近主打产品Purtier鹿胎盘素(Purtier Placenta)在推销过程,宣称产品是以鹿胎素提炼,是一种干细胞治疗方案,透过摄入药丸便能达其治疗效果。 卫生科学局发言人对此表示,目前仍在调查中。 “对于提供误导信息的产品,一旦发现有任何违反法律的行为,我们将严格采取法律行动,厂商若被发现有夸大、过度宣传或谎报药效的行为,会有被检控之虞,一旦罪成,可能会面临最高两年的监禁或被罚款最高5000新元” 直销商宣称治疗严重疾病效果佳,出现误导信息 自2017年1月起,消费者协会已陆续收到6起有关产品的投诉案件,其中3三起案件以产品含误导信息向协会投诉。 《海峡时报》指出,直销商宣称许多身患癌症、哮喘或中风的严重疾病者在服用该产品后得到好转,而该公司的收入也因产品的好销量而从2009年300万美元营收增至2017年40亿美元营收,以此向消费者证明产品的良好药效。 卫生科学局强调,针对主打干细胞治疗方案的医疗产品,民众需特别谨慎,他表示,“截至目前仍未有有力的科学证据,证明活细胞治疗方案的有效性。” “与此同时,并无任何医学证明口服干细胞能够预防或治疗疾病的证据。基本上,当我们将干细胞服用后,胰脏内的酶素只会将干细胞破坏而已,无法产生任何疗效。” “未有科学证明”…